The reno-protective effect of SGLT2 inhibitors has been reported in models of diabetes-related hyperfiltration (28) and in mice with Western diet-induced obesity (11), but it was unknown whether they influence renal hemodynamic in hypertensive rats with reduction in renal function reserve and HFD. This evidence concerns the gene SLC5A2 and obesity due to melanocortin 4 receptor deficiency.